Latest news
Entropy Neurodynamics Secures Ethics Approval for 72-Patient, Eight-Indication TRP-8803 Basket Study - KalkineKalkine · Tue, 04 Aug 2026 03:54:05 GMTEntropy Neurodynamics advances TRP-8803 with 72 patient psychedelic therapy trial - BiotechDispatchBiotechDispatch · Tue, 04 Aug 2026 00:14:52 GMTASX Quarterly Healthcare Wrap - Adelaide NowAdelaide Now · Wed, 29 Jul 2026 01:41:21 GMTEntropy Neurodynamics CEO to Present Clinical Progress and TRP-8803 Platform at TechKnow Invest Roadshow - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMTEntropy Neurodynamics CEO to Present TRP-8803 Psilocin Programme at TechKnow Invest Roadshow - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMTEntropy Neurodynamics CEO to Showcase Clinical Advances and TRP-8803 Platform at TechKnow Invest Roadshow - Kalkine MediaKalkine Media · Sun, 26 Jul 2026 23:15:02 GMT